Last updated on September 2017

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL


Brief description of study

This international, multi-center, Phase 2/3 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with Alport syndrome. The Phase 2 portion of the trial will be open-label and enroll up to 30 patients. The Phase 3 portion of the trial will be double-blind, randomized, placebo-controlled and will enroll up to 180 patients.

Detailed Study Description

This international, multi-center, Phase 2/3 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with Alport syndrome. The Phase 2 portion of the trial will be open-label and enroll up to 30 patients. The Phase 3 portion of the trial will be double-blind, randomized, placebo-controlled and will enroll up to 180 patients. Patients in the Phase 2 cohort will receive bardoxolone methyl throughout the study. Patients in the Phase 3 cohort will be randomized 1:1 to either bardoxolone methyl or placebo and randomization will be stratified by baseline albumin to creatinine ratio (ACR). Patients randomized to placebo will remain on placebo throughout the study, undergoing sham titration. All patients in the study will follow the same visit and assessment schedule. Following randomization on Day 1, patients will be scheduled to be assessed during treatment at Weeks 1, 2, 4, 6, 8, 12, 24, 36, 48, 52, 64, 76, 88, 100, and 104 and by telephone contact on Days 3, 10, 21, 31, 38, and 45. Patients will not receive study drug during a 4-week withdrawal period between Weeks 48 and 52. They will re-start treatment at Week 52 at the same dose they received at Week 48 and will continue study drug treatment through Week 100. Patients will also be scheduled to be assessed at an in person follow up visit at Week 104, four weeks after the end of treatment.

Clinical Study Identifier: NCT03019185

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dana Rizk, MD

University of Alabama at Birmingham
Birmingham, AL United States
  Connect »

Peter Santos, MD

AKDHC Medical Research Services, LLC
Phoenix, AZ United States
  Connect »

Caitlin Carter, MD

Scripps Clinic, Nephrology
La Jolla, CA United States
  Connect »

Mohamed El-Shahawy, MD

Academic Medical Research Institute
Los Angeles, CA United States
  Connect »

Anjay Rastogi, MD

David Geffen School of Medicine at UCLA
Los Angeles, CA United States
  Connect »

Sahar Barayan, MD

Valley Children's Healthcare
Madera, CA United States
  Connect »

Farzana Perwad, MD

UCSF
San Francisco, CA United States
  Connect »

Geoffrey Block, MD

Denver Nephrologists PC
Denver, CO United States
  Connect »

Edouard Martin, MD

South Florida Research Institute
Lauderdale Lakes, FL United States
  Connect »

Larry Greenbaum, MD

Emory University School of Medicine and Children's Healthcare of Atlanta
Atlanta, GA United States
  Connect »

Arnold Silva, MD

Boise Kidney & Hypertension Institute
Caldwell, ID United States
  Connect »

Arnold Silva, MD

Boise Kidney & Hypertension Institute
Meridian, ID United States
  Connect »

Stuart Sprague, MD

NorthShore University Health System
Evanston, IL United States
  Connect »

Mario Belledonne, MD

Biolab Research, LLC
Rockville, MD United States
  Connect »

Lesley Inker, MD

Tufts Medical Center
Boston, MA United States
  Connect »

Larysa Wickman, MD

University of Michigan
Ann Arbor, MI United States
  Connect »

Michelle Rheault, MD

University of Minnesota - Division of Pediatric Nephrology
Minneapolis, MN United States
  Connect »

Bradley Warady, MD

Children's Mercy Hospital - Kansas City
Kansas City, MO United States
  Connect »

George Jarad, MD

Washington University School of Medicine
Saint Louis, MO United States
  Connect »

Bruce Spinowitz, MD

Nephrology Associates, PC
Flushing, NY United States
  Connect »

Gerald Appel, MD

Columbia University Nephrology
New York, NY United States
  Connect »

Gregory Greenwood, MD

Nephrology Associates, PLLC
Winston-Salem, NC United States
  Connect »

Kotagal Kant, MD

University of Cincinnati
Cincinnati, OH United States
  Connect »

James Simon, MD

Cleveland Clinic
Cleveland, OH United States
  Connect »

Mohammed Faizan, MD

Rhode Island Hospital
Providence, RI United States
  Connect »

Moustafa Moustafa, MD

South Carolina Nephrology & Hypertension Center, Inc
Orangeburg, SC United States
  Connect »

Bernard Fischbach, MD

Renal Disease Research Institute
Dallas, TX United States
  Connect »

Marializa Bernardo, MD

Southwest Houston Research
Houston, TX United States
  Connect »

Pablo Pergola, MD

Clinical Advancement Center
San Antonio, TX United States
  Connect »

Josephine Abrahams, MD

University of Utah Health
Salt Lake City, UT United States
  Connect »